Koninklijke Philips (NYSE:PHG) Given Average Rating of “Hold” by Analysts

Koninklijke Philips (NYSE:PHG) has been assigned a consensus rating of “Hold” from the five analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company.

Several research firms have recently commented on PHG. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research report on Tuesday, October 29th. StockNews.com downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Thursday, November 14th.

Koninklijke Philips Price Performance

Shares of PHG stock opened at $25.82 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. The firm’s 50 day moving average price is $25.85 and its 200-day moving average price is $28.05. Koninklijke Philips has a one year low of $19.55 and a one year high of $32.91.

Hedge Funds Weigh In On Koninklijke Philips

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHG. Fairscale Capital LLC purchased a new stake in shares of Koninklijke Philips during the second quarter worth $54,000. Wilmington Savings Fund Society FSB acquired a new position in Koninklijke Philips during the 3rd quarter worth $54,000. Eastern Bank purchased a new stake in Koninklijke Philips during the 3rd quarter worth about $88,000. RPg Family Wealth Advisory LLC acquired a new stake in Koninklijke Philips in the 3rd quarter valued at about $107,000. Finally, Headlands Technologies LLC raised its position in Koninklijke Philips by 43.9% in the 2nd quarter. Headlands Technologies LLC now owns 6,561 shares of the technology company’s stock valued at $165,000 after purchasing an additional 2,003 shares in the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.